Effectiveness of long-term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center

BACKGROUND: Diabetes is a progressive disease needing multiple drugs for achieving and maintaining good glycemic control. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) is a novel class of anti-diabetic agent which offers several beneficial effects. However, the long-term effectiveness in clini...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Diabetol Metab Syndr
Asıl Yazarlar: Thewjitcharoen, Yotsapon, Yenseung, Nalin, Malidaeng, Areeya, Nakasatien, Soontaree, Chotwanvirat, Phawinpon, Krittiyawong, Sirinate, Wanothayaroj, Ekgaluck, Himathongkam, Thep
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2017
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5709980/
https://ncbi.nlm.nih.gov/pubmed/29213337
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-017-0297-y
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller